GXYLT2 and prostate carcinoma: KEGG analysis of mRNAs in the lncRNA-miRNA-mRNA regulatory network showed that GXYLT2 was enriched in other types of O-glycan biosynthesis, and AR was enriched in prostate cancer and oocyte meiosis pathways (Fig. 7A).